Following a full submission
AWMSG advice |
|||
| Status: Recommended | |||
Ivermectin (Soolantra®) is recommended as an option for use within NHS Wales for the topical treatment of inflammatory lesions of rosacea (papulopustular) in adult patients. |
|||
|
|||
Medicine details |
|||
| Medicine name | ivermectin (Soolantra®) | ||
| Formulation | 10 mg/g cream | ||
| Reference number | 1627 | ||
| Indication | Treatment of inflammatory lesions of rosacea (papulopustular) in adult patients |
||
| Company | Galderma (UK) Ltd | ||
| BNF chapter | Skin | ||
| Submission type | Full | ||
| Status | Recommended | ||
| Advice number | 0216 | ||
| NMG meeting date | 20/01/2016 | ||
| AWMSG meeting date | 24/02/2016 | ||
| Ratification by Welsh Government | 24/03/2016 | ||
| Date of issue | 01/04/2016 | ||
| Date of last review | 20/03/2019 | ||